BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liang S, Wang Q, Qi X, Liu Y, Li G, Lu S, Mou L, Chen X. Deciphering the Mechanism of Gilteritinib Overcoming Lorlatinib Resistance to the Double Mutant I1171N/F1174I in Anaplastic Lymphoma Kinase. Front Cell Dev Biol 2021;9:808864. [PMID: 35004700 DOI: 10.3389/fcell.2021.808864] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Cao S, Tan C, Fei A, Hu G, Fu M, Lv J. Insights into pralsetinib resistance to the non-gatekeeper RET kinase G810C mutation through molecular dynamics simulations. J Mol Model 2022;29:24. [PMID: 36576611 DOI: 10.1007/s00894-022-05429-9] [Reference Citation Analysis]
2 Zheng G, Li M, Zhang J, Liu W, Jiang L, Liang W, Wang J, Shi H, Kang Z, Zhou B. A computational study to reveal selpercatinib resistance to RET kinase double mutant V804M/Y806C. Chem Pap . [DOI: 10.1007/s11696-022-02479-4] [Reference Citation Analysis]
3 Liu C, Zhang Y, Zhang Y, Liu Z, Mao F, Chai Z. Mechanistic Insights into the Mechanism of Inhibitor Selectivity toward the Dark Kinase STK17B against Its High Homology STK17A. Molecules 2022;27:4655. [DOI: 10.3390/molecules27144655] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Shi Y, Cao S, Ni D, Fan J, Lu S, Xue M. The Role of Conformational Dynamics and Allostery in the Control of Distinct Efficacies of Agonists to the Glucocorticoid Receptor. Front Mol Biosci 2022;9:933676. [DOI: 10.3389/fmolb.2022.933676] [Reference Citation Analysis]
5 Baba K, Goto Y. Lorlatinib as a treatment for ALK-positive lung cancer. Future Oncol 2022. [PMID: 35787143 DOI: 10.2217/fon-2022-0184] [Reference Citation Analysis]
6 Ji M, Chai Z, Chen J, Li G, Li Q, Li M, Ding Y, Lu S, Ju G, Hou J. Insights into the Allosteric Effect of SENP1 Q597A Mutation on the Hydrolytic Reaction of SUMO1 via an Integrated Computational Study. Molecules 2022;27:4149. [DOI: 10.3390/molecules27134149] [Reference Citation Analysis]
7 Liu C, Li Z, Liu Z, Yang S, Wang Q, Chai Z. Understanding the P-Loop Conformation in the Determination of Inhibitor Selectivity Toward the Hepatocellular Carcinoma-Associated Dark Kinase STK17B. Front Mol Biosci 2022;9:901603. [DOI: 10.3389/fmolb.2022.901603] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 He X, Du K, Wang Y, Fan J, Li M, Ni D, Lu S, Bian X, Liu Y. Autopromotion of K-Ras4B Feedback Activation Through an SOS-Mediated Long-Range Allosteric Effect. Front Mol Biosci 2022;9:860962. [DOI: 10.3389/fmolb.2022.860962] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]